Clinical Research Trial Enrollment

Psychedelic (5-MeO-DMT) for Depression

This study is investigating the effects of  BPL-003 (a formulation of the psychedelic 5-MeO-DMT) on Treatment Resistant Depression. The sponsor of the study is Beckley Psytech Ltd. 

Please complete this short survey to assess your initial eligibility for this trial

If you are experiencing issues completing the survey on this page, please press here:

Direct Survey Link

Dr feifel team

Principal Investigator

This study is done at Kadima Neuropsychiatry Institute in La Jolla

Scroll to Top